Addex Therapeutics LtdADXNNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank26
Year-over-Year Change
Year-over-year book value per share growth
Latest
-36.56%
↓ 155% vs avg
Percentile
P26
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
67.08%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | -36.56% |
| Q2 2025 | -1.18% |
| Q1 2025 | -14.73% |
| Q4 2024 | -12.78% |
| Q3 2024 | -12.56% |
| Q2 2024 | 1019.85% |
| Q1 2024 | -217.24% |
| Q4 2023 | -76.44% |
| Q3 2023 | -39.85% |
| Q2 2023 | 27.67% |
| Q1 2023 | -19.23% |
| Q4 2022 | -50.54% |
| Q3 2022 | -9.15% |
| Q2 2022 | -46.42% |
| Q1 2022 | -29.78% |
| Q4 2021 | 24.52% |
| Q3 2021 | -18.91% |
| Q2 2021 | -21.92% |
| Q1 2021 | 13.13% |
| Q4 2020 | -7.48% |
| Q3 2020 | -16.32% |
| Q2 2020 | -13.89% |
| Q1 2020 | -15.54% |
| Q4 2019 | 0.00% |
| Q3 2019 | -100.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | -100.00% |
| Q4 2018 | -1.60% |
| Q3 2018 | -30.49% |
| Q2 2018 | 17.88% |
| Q1 2018 | 1678.12% |
| Q4 2017 | -15.37% |
| Q3 2017 | -36.18% |
| Q2 2017 | -8.72% |
| Q1 2017 | 1020.20% |
| Q4 2016 | -49.52% |
| Q3 2016 | -57.82% |
| Q2 2016 | -38.07% |
| Q1 2016 | -9.18% |
| Q4 2015 | -10.52% |